These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28667292)

  • 41. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies.
    Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC
    Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tyrosinase gene mutations in the Chinese Han population with OCA1.
    Liu N; Kong XD; Shi HR; Wu QH; Jiang M
    Genet Res (Camb); 2014 Nov; 96():e14. PubMed ID: 25577957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oculocutaneous albinism type 1A: a case report.
    Karaman A
    Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel deletion of exon 3 in TYR gene causing Oculocutaneous albinism 1B in an Indian family along with intellectual disability associated with chromosomal copy number variations.
    Dhangar S; Panchal P; Ghatanatti J; Suralkar J; Shah A; Vundinti BR
    BMC Med Genomics; 2022 Jan; 15(1):2. PubMed ID: 34980106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.
    Durham-Pierre D; Gardner JM; Nakatsu Y; King RA; Francke U; Ching A; Aquaron R; del Marmol V; Brilliant MH
    Nat Genet; 1994 Jun; 7(2):176-9. PubMed ID: 7920637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tyrosinase gene analysis in Japanese patients with oculocutaneous albinism.
    Goto M; Sato-Matsumura KC; Sawamura D; Yokota K; Nakamura H; Shimizu H
    J Dermatol Sci; 2004 Sep; 35(3):215-20. PubMed ID: 15381243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Early prenatal genetic diagnosis of oculocutaneous albinism type I in seven families].
    Wu Q; Shi HR; Liu N; Lu N; Jiang M; Zhao ZH; Kong XD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):377-81. PubMed ID: 22875490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular basis of oculocutaneous albinism.
    Oetting WS; King RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families.
    Wei AH; Zang DJ; Zhang Z; Yang XM; Li W
    J Genet Genomics; 2015 Jun; 42(6):279-86. PubMed ID: 26165494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
    Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y
    J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of a novel mutation (p.Ile198Thr) in gene TYR in a Pakistani family with nonsyndromic oculocutaneous albinism.
    Shah SA; Din SU; Raheem N; Daud S; Mubeen J; Nadeem A; Tayyab M; Baloch DM; Babar ME; Ahmad J
    Clin Exp Dermatol; 2014 Jul; 39(5):646-8. PubMed ID: 24934919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prenatal gene diagnosis of oculocutaneous albinism type I].
    Li HY; Wu WI; Zheng H; Duan HL; Chen Z; Chen LM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):280-2. PubMed ID: 16767664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosinase gene (TYR) mutations in Chinese patients with oculocutaneous albinism type 1.
    Liu J; Choy KW; Chan LW; Leung TY; Tam PO; Chiang SW; Lam DS; Pang CP; Lai TY
    Clin Exp Ophthalmol; 2010 Jan; 38(1):37-42. PubMed ID: 20447099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. After an initial Hermansky-Pudlak syndrome clinical diagnosis, molecular testing reveals variants for oculocutaneous albinism type 1B: A case report.
    Serrano-González J; Montes-Rodríguez I; Renta JY; Rojas R; Cadilla CL
    Mol Genet Genomic Med; 2024 Jul; 12(7):e2493. PubMed ID: 38994739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).
    Lee ST; Nicholls RD; Schnur RE; Guida LC; Lu-Kuo J; Spinner NB; Zackai EH; Spritz RA
    Hum Mol Genet; 1994 Nov; 3(11):2047-51. PubMed ID: 7874125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oculocutaneous albinism type 1: the last 100 years.
    Oetting WS; Fryer JP; Shriram S; King RA
    Pigment Cell Res; 2003 Jun; 16(3):307-11. PubMed ID: 12753405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing.
    Gul H; Ali MZ; Khan E; Zubair M; Badar M; Khan S; Shah AH; Khan MA
    J Pak Med Assoc; 2017 May; 67(5):790-792. PubMed ID: 28507374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
    Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.